Physicochemical Properties
| Molecular Formula | C26H21FN2O4S |
| Molecular Weight | 476.5193 |
| Exact Mass | 476.121 |
| Elemental Analysis | C, 65.53; H, 4.44; F, 3.99; N, 5.88; O, 13.43; S, 6.73 |
| CAS # | 727699-84-5 |
| PubChem CID | 5020799 |
| Appearance | White to off-white solid powder |
| LogP | 4.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Heavy Atom Count | 34 |
| Complexity | 751 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | S(C1C([H])=C([H])C(=C([H])C=1[H])F)(N([H])C1=C(C([H])=C([H])C(=C1[H])N([H])C(C1C([H])=C([H])C(=C([H])C=1[H])C1C([H])=C([H])C([H])=C([H])C=1[H])=O)OC([H])([H])[H])(=O)=O |
| InChi Key | DVLMVJILWFSRPS-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C26H21FN2O4S/c1-33-25-16-13-22(17-24(25)29-34(31,32)23-14-11-21(27)12-15-23)28-26(30)20-9-7-19(8-10-20)18-5-3-2-4-6-18/h2-17,29H,1H3,(H,28,30) |
| Chemical Name | N-[3-[(4-fluorophenyl)sulfonylamino]-4-methoxyphenyl]-4-phenylbenzamide |
| Synonyms | DUN99845; DUN-99845; DUN 99845; |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Targeting the human STING's cyclic dinucleotide binding pocket is SN-001 [1]. In a dose-dependent manner, SN-001 (5–20 μM; 6 hours) significantly reduces the induction of Ifnb mRNA in L929 cells [1]. Cytosolic DNA-induced STING signaling is inhibited by SN-001 (10 μM; 3 hours) [1]. |
| Cell Assay |
Western Blot Analysis[1] Cell Types: L929 Cell Tested Concentrations: 10 μM Incubation Duration: 3 hrs (hours) Experimental Results: Cytoplasmic DNA-induced reduction in STING, TBK1, IRF3, IκBα and p65 phosphorylation and nuclear translocation of IRF3 and p65. |
| References |
[1]. STING inhibitors target the cyclic dinucleotide binding pocket. Proc Natl Acad Sci U S A. 2021 Jun 15;118(24):e2105465118. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~250 mg/mL (~524.64 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (4.36 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.0985 mL | 10.4927 mL | 20.9855 mL | |
| 5 mM | 0.4197 mL | 2.0985 mL | 4.1971 mL | |
| 10 mM | 0.2099 mL | 1.0493 mL | 2.0985 mL |